Linux From Scratch 13.0 inaugura l’era systemd‑only Linux From Scratch 13.0 segna una svolta storica: arriva la prima versione solo systemd, con pacchetti aggiornati e kernel recente

Linux From Scratch 13.0 introduce la prima edizione esclusivamente basata su systemd, aggiorna i componenti fondamentali e rinnova anche BLFS 13.0 con un ampio ventaglio di software aggiuntivo. Una panoramica completa sulle novità della nuova versione. #LinuxFromScratch #LFS13 #systemd #BLFS #Linux

BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations Fourth quarter 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year 2025 revenue of $96.2 million, up 29% year-over-year. GAAP net income of $2.1 million or $0.04 per share and adjusted EBITDA of $6.9 million, or 28% of total revenue for the fourth quarter. Expects 2026 revenue growth of $112.5 million to $115.0 million, up...

#BLFS BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

www.stocktitan.net/news/BLFS/bio-life-solut...

Linux From Scratch gibt SysVinit-Unterstützung auf Linux From Scratch wird die Unterstützung für SysVinit mit Version 13.0 ab März 2026 aufgeben. Die Gründe sind zu hohe Arbeitsbelastung und zunehmende Dominanz von systemd.

Linux From Scratch gibt SysVinit-Unterstützung auf linuxnews.de/linux-from-s... #lfs #blfs #linuxfromscratch #sysvinit #linux #linuxnews

BioLife Solutions Reports Third Quarter 2025 Financial Results BioLife Solutions (Nasdaq: BLFS) reported Q3 2025 results showing continued growth in its core cell processing business. Cell Processing revenue rose 33% YoY to $25.4M, total revenue was $28.1M (up 31% YoY), and adjusted EBITDA was $7.8M (28% of revenue). GAAP net income for Q3 was $0.6M. Management raised 2025 Cell Processing revenue guidance to $93.0M–$94.0M and total revenue guidance (post-evo sale) to $95.0M–$96.0M. The company completed the sale of its evo cold chain business for $25.5M in early October 2025.

#BLFS BioLife Solutions Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/BLFS/bio-life-solut...

BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary BioLife Solutions (Nasdaq: BLFS) announced the sale of its wholly owned cold chain logistics subsidiary, SAVSU Cleo Technologies (f/k/a SAVSU Technologies), to Peli BioThermal for $25.5 million in cash, subject to customary adjustments.The company said the divestiture will streamline its product portfolio and operations to concentrate resources on high-margin recurring revenue in its core cell and gene therapy tools and services business.

#BLFS BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary

www.stocktitan.net/news/BLFS/bio-life-solut...

Small-cap stocks with declining money flow, Tue Jul 8th - #ULCC #RAPT #PRTA #MRKR #LTBR #KIRK #IKNA #GLRE #FDMT #EVAX #ONTH #STAA #TVNA #BLFS #BRCP #AYTU #ZEPP #VLRS #SEMR #OBK #LUXE #HBI #CHCG #REPL - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Breaking News: ( NASDAQ: #BLFS ) When (BLFS) Moves Investors should Listen

BioLife Solutions Reports First Quarter 2025 Financial Results BioLife Solutions (NASDAQ: BLFS) reported strong Q1 2025 financial results, with total revenue reaching $23.9 million, up 30% year-over-year. Cell Processing revenue grew 33% to $21.6 million. The company achieved a GAAP gross margin of 63% and reported a reduced GAAP net loss of $0.4 million, with adjusted EBITDA of $5.7 million (24% of revenue). BioLife's biopreservation media is now embedded in 17 commercial cell and gene therapies, with 10 additional approvals expected in the next 12 months. The company completed the acquisition of PanTHERA CryoSolutions in April 2025. BioLife affirmed its 2025 revenue guidance of $95.5-99.0 million, representing 16-20% growth. The company maintains a strong financial position with $107.6 million in cash and marketable securities.

#BLFS BioLife Solutions Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/BLFS/bio-life-solut...

#BLFS 12.3 has been released ( #BeyondLinuxFromScratch / #LinuxFromScratch / #LFS / #Linux ) linuxfromscratch.org/blfs/

Can BioLife's 37% Cell Processing Growth Propel Its Stock Higher in 2025? BioLife achieves 31% Q4 revenue growth with 60% gross margin, strengthens balance sheet to $109M cash, and projects 16-20% revenue growth for 2025.

#BLFS BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/BLFS/bio-life-solut...

BioLife Solutions Reports Strong Q4: Cell Processing Revenue Surges 37% to $20.3M BioLife Solutions delivers robust Q4 performance with total revenue up 31% YoY to $22.7M, driven by Cell Processing platform growth. Full-year revenue reaches $82.3M amid strategic focus.

#BLFS BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations

www.stocktitan.net/news/BLFS/bio-life-solut...

#BLFS BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary

www.stocktitan.net/news/BLFS/bio-life-solut...

JUST IN: ( NASDAQ: #BLFS ) BioLife Solutions Inc. (NASDAQ: BLFS) Climbs to New 52-Week High

#StockMarket #News

Linux From Scratch 12.1 was released | linuxfromscratch.org | #linuxfromscratch #lfs #blfs #linux